#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroblastoma recurrent Multiple system atrophy Sarcoma Mucopolysaccharidosis II B-cell lymphoma Encephalitis autoimmune Blood iron increased Pyruvate kinase deficiency anaemia Microvillous inclusion disease Familial amyotrophic lateral sclerosis Acquired haemophilia Ependymoma Cutaneous lupus erythematosus Cystic fibrosis respiratory infection suppression Diffuse large B-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Sarcoidosis – Life with Disease Nodal marginal zone B-cell lymphoma – Diagnostics Mucopolysaccharidosis III – Life with Disease Rhabdomyosarcoma recurrent – Diagnostics Uterine leiomyosarcoma – Diagnostics Hereditary motor and sensory neuropathy – Diagnostics Myelodysplastic syndrome – Life with Disease Sjogren’s syndrome – Life with Disease Glycogen storage disease type I Congenital nephrogenic diabetes insipidus – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tobramycin CLESROVIMAB Rbp030.2 Op-1250 LUNSEKIMIG Furosemide Ph. Eur. Obeticholic Acid [14C] DC-806 Insulin Glargine Seralutinib Ribonucleic Acid K10 Bedaquiline Amiloride Zanubrutinib Iron Sucrose Ttf-Ngr [89ZR]ZR-DFO-CIT-013 CILOSTAZOL Ranolazine Fosfomycin Trometamol More therapies…

    Learn about Your Condition

    Femoral neck fracture Ependymoma malignant Ocular melanoma Hyperplasia adrenal Fibromyalgia T-cell type acute leukaemia Systemic mastocytosis Biopsy heart Incisional hernia Dementia Alzheimer's type Meningioma malignant Amnestic disorder Thalassaemia alpha Hepatic neoplasm Meniscus injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer

  • Comparing Pain Relief Methods in Colorectal Cancer Surgery: TAP Block vs. Port Site Infiltration with Levobupivacaine for Patients in ERAS Program

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Levobupivacaine
    Spain

  • Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark Finland Norway Sweden

  • Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to rectum
    • Colorectal cancer
    • Colorectal cancer metastatic
    The Netherlands

  • Study on Bevacizumab and Drug Combination for Patients with Resectable Colorectal Peritoneal Metastases

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    • Colorectal cancer
    Investigated Drugs:
    • Bevacizumab
    • Capecitabine
    • Fluorouracil
    Belgium The Netherlands

  • Study of INCB099280 and Adagrasib for Adults with Advanced Solid Tumors with KRASG12C Mutation

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Incb099280
    • Adagrasib
    France Italy Spain

  • Study on Irinotecan and mFOLFOX4-Bevacizumab for Patients with Resectable Colorectal Peritoneal Metastases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    • Colorectal cancer
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    The Netherlands
Previous Page
1 … 8 9 10 11 12 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!